GO
Loading...

Bristol-Myers Squibb Co

More

  • COPENHAGEN, March 4- Shares in Bavarian Nordic leapt as much as 39 percent on Wednesday after the Danish biotech company announced a prostate cancer drug deal with Bristol-Myers Squibb that could be worth at least $1 billion. Under the deal, Bavarian Nordic could receive up to $975 million, including $60 million upfront, if it passes trials and sales milestones,...

  • Final Glance: Pharmaceuticals companies Tuesday, 3 Mar 2015 | 6:05 PM ET

    Baxter International Inc. fell$. 54 or. 8 percent, to $69.42. Bristol-Myers Squibb Co. fell$. 38 or. 6 percent, to $61.92. Eli Lilly& Co. fell$. 75 or 1.1 percent, to $70.37.

  • Final Glance: Pharmaceuticals companies Monday, 2 Mar 2015 | 6:08 PM ET

    Baxter International Inc. rose$. 81 or 1.2 percent, to $69.96. Bristol-Myers Squibb Co. rose $1.38 or 2.3 percent, to $62.30. Eli Lilly& Co. rose$. 95 or 1.4 percent, to $71.12.

  • Early Glance: Pharmaceuticals companies Monday, 2 Mar 2015 | 11:16 AM ET

    Baxter International Inc. rose$. 34 or. 5 percent, to $69.49. Bristol-Myers Squibb Co. rose$. 81 or 1.3 percent, to $61.73. Eli Lilly& Co. rose$. 78 or 1.1 percent, to $70.95.

  • Final Glance: Pharmaceuticals companies Friday, 27 Feb 2015 | 6:02 PM ET

    Baxter International Inc. rose$. 48 or. 7 percent, to $69.15. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.92. Eli Lilly& Co. rose$. 14 or. 2 percent, to $70.17.

  • Midday Glance: Pharmaceuticals companies Friday, 27 Feb 2015 | 1:26 PM ET

    Baxter International Inc. rose$. 69 or 1.0 percent, to $69.36. Bristol-Myers Squibb Co. fell$. 26 or. 4 percent, to $61.20. Eli Lilly& Co. rose$. 32 or. 5 percent, to $70.35.

  • Early Glance: Pharmaceuticals companies Friday, 27 Feb 2015 | 11:10 AM ET

    Baxter International Inc. rose$. 33 or. 5 percent, to $69.00. Eli Lilly& Co. fell$. 03 or percent, to $70.00. Hospira fell$. 03 or percent, to $87.51.

  • Final Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 6:02 PM ET

    Baxter International Inc. fell$. 19 or. 3 percent, to $68.67. Bristol-Myers Squibb Co. rose$. 24 or. 4 percent, to $61.46. Eli Lilly& Co. fell$. 33 or. 5 percent, to $70.03.

  • Midday Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 1:19 PM ET

    Baxter International Inc. fell$. 03 or percent, to $68.83. Bristol-Myers Squibb Co. rose$. 27 or. 4 percent, to $61.49. Eli Lilly& Co. fell$. 57 or. 8 percent, to $69.79.

  • Early Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 10:35 AM ET

    Baxter International Inc. fell$. 11 or. 2 percent, to $68.75. Bristol-Myers Squibb Co. fell$. 42 or. 7 percent, to $60.80. Eli Lilly& Co. fell$. 70 or 1.0 percent, to $69.66.

  • Midday Glance: Pharmaceuticals companies Wednesday, 25 Feb 2015 | 1:18 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $68.90. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $61.30. Eli Lilly& Co. fell$. 24 or. 3 percent, to $70.66.

  • Early Glance: Pharmaceuticals companies Wednesday, 25 Feb 2015 | 11:23 AM ET

    Baxter International Inc. fell$. 09 or. 1 percent, to $68.97. Bristol-Myers Squibb Co. fell$. 40 or. 7 percent, to $61.05. Johnson& Johnson fell$. 40 or. 4 percent, to $100.30.

  • Final Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 6:02 PM ET

    Baxter International Inc. rose$. 42 or. 6 percent, to $69.06. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $61.45. Eli Lilly& Co. fell$. 19 or. 3 percent, to $70.90.

  • Feb 24- An experimental therapeutic vaccine from Danish drugmaker Bavarian Nordic helped significantly extend survival in patients with advanced prostate cancer, according to results of a small early-stage trial conducted by the U.S. National Cancer Institute. Patients were treated with the company's Prostvac vaccine, in addition to escalating doses of...

  • Midday Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 1:17 PM ET

    Baxter International Inc. rose$. 27 or. 4 percent, to $68.91. Bristol-Myers Squibb Co. fell$. 10 or. 2 percent, to $61.19. Eli Lilly& Co. fell$. 26 or. 4 percent, to $70.83.

  • Early Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 11:24 AM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $68.86. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.75. Eli Lilly& Co. fell$. 15 or. 2 percent, to $70.94.

  • Final Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 6:04 PM ET

    Baxter International Inc. rose$. 74 or 1.1 percent, to $68.64. Bristol-Myers Squibb Co. rose$. 77 or 1.3 percent, to $61.29. Eli Lilly& Co. fell$. 79 or 1.1 percent, to $71.09.

  • Midday Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 1:20 PM ET

    Baxter International Inc. rose$. 72 or 1.1 percent, to $68.62. Bristol-Myers Squibb Co. rose$. 65 or 1.1 percent, to $61.17. Eli Lilly& Co. fell$. 99 or 1.4 percent, to $70.89.

  • Early Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 10:40 AM ET

    Baxter International Inc. rose$. 63 or. 9 percent, to $68.53. Bristol-Myers Squibb Co. rose$. 17 or. 3 percent, to $60.69. Eli Lilly& Co. fell$. 65 or. 9 percent, to $71.23.

  • NEW YORK— Bristol-Myers Squibb is using an acquisition that could be worth more than $1 billion and a separate collaboration agreement to continue its push into developing cancer treatments that use a patient's immune system to attack the disease. The New York drugmaker said Monday that it will buy the privately held biotechnology company Flexus for $800...